These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31031849)

  • 1. High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma.
    Tichý M; Knopfová L; Jarkovský J; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
    J Cancer; 2019; 10(6):1393-1397. PubMed ID: 31031849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myb regulates NOX1/p38 to control survival of colorectal carcinoma cells.
    Pekarčíková L; Knopfová L; Beneš P; Šmarda J
    Cell Signal; 2016 Aug; 28(8):924-36. PubMed ID: 27107996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings.
    Biroccio A; Benassi B; D'Agnano I; D'Angelo C; Buglioni S; Mottolese M; Ricciotti A; Citro G; Cosimelli M; Ramsay RG; Calabretta B; Zupi G
    Am J Pathol; 2001 Apr; 158(4):1289-99. PubMed ID: 11290547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of c-Myb is associated with suppression of distant metastases in colorectal carcinoma.
    Tichý M; Knopfová L; Jarkovský J; Pekarčíková L; Veverková L; Vlček P; Katolická J; Čapov I; Hermanová M; Šmarda J; Beneš P
    Tumour Biol; 2016 Aug; 37(8):10723-9. PubMed ID: 26873484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
    Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
    Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2.
    Yang IP; Tsai HL; Huang CW; Lu CY; Miao ZF; Chang SF; Juo SH; Wang JY
    Oncotarget; 2016 Apr; 7(14):18837-50. PubMed ID: 26934556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
    Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG
    Oncogene; 2016 May; 35(19):2475-84. PubMed ID: 26300002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands: A Clinicopathologic Study With Correlation Between MYB Fusion and Protein Expression.
    Xu B; Drill E; Ho A; Ho A; Dunn L; Prieto-Granada CN; Chan T; Ganly I; Ghossein R; Katabi N
    Am J Surg Pathol; 2017 Oct; 41(10):1422-1432. PubMed ID: 28719465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
    Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
    Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia.
    Svec J; Musílková J; Bryndová J; Jirásek T; Mandys V; Kment M; Pácha J
    Inflamm Bowel Dis; 2010 Jul; 16(7):1127-37. PubMed ID: 20027603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Cancer Prognosis is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study.
    Lee JH; Ahn J; Park WS; Choe EK; Kim E; Shin R; Heo SC; Jung S; Kim K; Chai YJ; Chae H
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30658510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB.
    Ramsay RG; Friend A; Vizantios Y; Freeman R; Sicurella C; Hammett F; Armes J; Venter D
    Cancer Res; 2000 Apr; 60(7):1805-9. PubMed ID: 10766162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
    BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
    Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
    Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
    Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
    [No Abstract]   [Full Text] [Related]  

  • 20. Strong association between c-myb and oestrogen-receptor expression in human breast cancer.
    Guérin M; Sheng ZM; Andrieu N; Riou G
    Oncogene; 1990 Jan; 5(1):131-5. PubMed ID: 2181374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.